Fmr LLC Foghorn Therapeutics Inc. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Fmr LLC holds 5,588,874 shares of FHTX stock, worth $23.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,588,874

Previous 5,689,719 1.77%

Holding current value

$23.3 Million

Previous $26.9 Million 24.04%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$3.52 - $6.16 $354,974 - $621,205	-100,845 Reduced 1.77%	5,588,874 $20.4 Million
Q4 2024 Feb 13, 2025	SELL	$4.61 - $9.35 $2.97 Million - $6.02 Million	-644,265 Reduced 10.17%	5,689,719 $26.9 Million
Q3 2024 Nov 13, 2024	SELL	$4.8 - $9.99 $236,673 - $492,576	-49,307 Reduced 0.77%	6,333,984 $59 Million
Q2 2024 Aug 13, 2024	BUY	$5.05 - $8.0 $18.6 Million - $29.5 Million	3,692,155 Added 137.2%	6,383,291 $36.7 Million
Q1 2024 May 13, 2024	SELL	$2.82 - $7.94 $335,221 - $943,851	-118,873 Reduced 4.23%	2,691,136 $18.1 Million
Q4 2023 Feb 13, 2024	SELL	$2.94 - $6.76 $259,337 - $596,299	-88,210 Reduced 3.04%	2,810,009 $18.1 Million
Q3 2023 Nov 13, 2023	SELL	$5.0 - $9.87 $47,530 - $93,824	-9,506 Reduced 0.33%	2,898,219 $14.5 Million
Q2 2023 Aug 11, 2023	SELL	$5.37 - $8.84 $576,131 - $948,417	-107,287 Reduced 3.56%	2,907,725 $20.5 Million
Q1 2023 May 11, 2023	SELL	$4.66 - $8.99 $477,100 - $920,414	-102,382 Reduced 3.28%	3,015,012 $18.7 Million
Q4 2022 Feb 13, 2023	SELL	$5.44 - $9.46 $1.63 Million - $2.83 Million	-298,938 Reduced 8.75%	3,117,394 $19.9 Million
Q3 2022 Nov 10, 2022	SELL	$7.52 - $18.01 $131,945 - $316,003	-17,546 Reduced 0.51%	3,416,332 $29.3 Million
Q2 2022 Aug 12, 2022	BUY	$8.48 - $16.84 $2.02 Million - $4.01 Million	238,012 Added 7.45%	3,433,878 $46.7 Million
Q1 2022 May 13, 2022	BUY	$8.87 - $22.1 $6.31 Million - $15.7 Million	711,032 Added 28.61%	3,195,866 $48.7 Million
Q4 2021 Feb 14, 2022	SELL	$10.79 - $22.87 $380,886 - $807,311	-35,300 Reduced 1.4%	2,484,834 $56.8 Million
Q3 2021 Nov 15, 2021	SELL	$8.33 - $15.02 $169,099 - $304,906	-20,300 Reduced 0.8%	2,520,134 $35.1 Million
Q2 2021 Aug 13, 2021	BUY	$9.32 - $13.26 $23.7 Million - $33.7 Million	2,540,434 New	2,540,434 $27.1 Million

Others Institutions Holding FHTX

# of Institutions

Shares Held

36.7M

Call Options Held

100

Put Options Held

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $174M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account